We recently reported a new approach for mild and site-selective bioconjugation that leverages the reactivity of organometallic reagents ( Figure 1) . 3 In the presence of preformed complexes of type LPd(Ar)X (L = biarylphosphine, X = Cl, Br, OTf), cysteine thiol groups formed S-C(sp 2 ) bonds to provide the respective S-arylated peptide or protein. By employing this operationally simple protocol, the arylation of cysteine-containing biomolecules is completed within minutes and in generally high yields. 4 Moreover, palladium complexes bearing a variety of functionalized aryl groups were compatible with these reaction conditions. Nevertheless, the potential chemical and biological lability of the resultant thioether linkage, as well as the scarcity of cysteine residues in peptides, limits the applicability of this protocol. Consequently, we set out to develop an alternative arylation protocol for the formation of stable bonds to amino acid residues that are more abundant in peptides and proteins.
We considered the arylation of the amino group in lysine as an alternative means of generating a stable bioconjugate. Among the various amino acid residues containing potentially reactive nitrogen atoms, we targeted lysine because of its nucleophilicity and unambiguous site of reactivity. Strategies used for the chemical modification of primary amines in polypeptides include conjugate addition, 5 condensation with an activated ester, 6 addition to a (thio)isocyanate or ketene, 7 and Schiff base formation/derivatization. 8 More recently, the reaction of acyl trifluoroborates with prefunctionalized hydroxylamine esters has also been reported. 9 Despite the utility of these protocols, important limitations still exist, including inadequate chemoselectivity, the requirement for a preactivated nucleophile, or the limited chemical stability of the respective conjugate.
Compared to cysteine bioconjugation, we anticipated that lysine conjugation would present additional challenges as a consequence of the lower nucleophilicity of the amino group and the lower acidity of the palladium-amine complex. To address the latter, we envisioned the use of a weak base to effect the requisite deprotonation. Importantly, this base would need to be relatively mild in order to avoid degradation of the polypeptide. In addition, a judiciously chosen ligand would be required to facilitate the desired C-N reductive elimination in preference to other palladium-mediated bond-forming processes. Herein we report the development of conditions to address these challenges, resulting in a general and selective protocol for the conjugation of aryl groups to peptidic lysine residues.
In initial optimization studies, a model peptide containing a lysine residue was exposed to preformed complexes of type LPd(Ar)Br (Ar = 4-anisyl) supported by a series of biarylphosphine ligands in the presence of sodium phenoxide as the base (Table 1 , entries 1-6). 10 Sodium phenoxide was selected due to its widespread availability and relatively low basicity (pK a [BH] = 10). 11 Notably, stability studies indicated that greater than 95% of the peptide substrate remained intact in the presence of sodium phenoxide (see the Supporting Information). It was discovered that the complex supported by t-BuBrettPhos exhibited the most pronounced reactivity at room temperature (Entry 5). 12 Unfortunately, a palladium complex bearing an electron deficient aryl group (4-CO 2 Me-Ph) afforded the arylation product in low yield due to competitive phenol and aryl ether formation under these conditions (Entry 7). 13 Improved results were obtained when t-BuBrettPhos was replaced with the less bulky BrettPhos, presumably due to the reduced propensity of the latter to facilitate C-O bond forming reductive elimination (Entry 8). Analysis of the reaction mixture by LC/MS indicated that partial arylation of the supporting ligand occurred, due to a previously observed arylative rearrangement of the palladium complex. 14 Thus, more than one equivalent of the palladium complex was required for full conversion of the peptide to the arylated product. 15 Next, we investigated the selectivity of this methodology by utilizing peptide substrates containing a lysine and another nucleophilic residue (Table 2) . Throughout this analysis, the position of modification was unambiguously determined by tandem MS/MS analysis. Although the presence of a cysteine residue was not tolerated due to competitive basemediated dehydroalanine formation, the current protocol was shown to be completely selective towards the modification of a lysine residue in the presence of serine, tyrosine, methionine, histidine, or tryptophan residues (Entries 1-5). Amino acid residues containing an amide (Entry 6) or a guanidine (Entry 7) 17 side chain could be used in this protocol, although diarylation was also observed. Similarly, the presence of a primary amine at the Nterminus 18 and an amide at the C-terminus gave rise to the corresponding diarylation product (Entries 8 and 9). 19 However, these side reactions could be completely suppressed by employing the Pd complex as the limiting reagent (Entries 6-9).
To demonstrate the utility of this developed protocol, we investigated the arylation of a complex bioactive peptide using LPd(Ar)X complexes with a variety of aryl groups (Scheme 1). We focused our attention on a tumor-suppressing peptide that targets a p53-MDM2 interaction. 20, 21 Using this method, an aryl group derived from the corresponding chloride, bromide, and triflate could be coupled to the respective peptide in comparable yields (1-3) . Complex functional molecules, such as natural product derivatives (4 22 and 5), conjugation/ affinity tags (6 and 7), chromophores (8 and 9), and complex drug molecules containing a chlorine atom (10-15), were successfully appended with high efficiency. Importantly, this protocol could be conducted on a larger scale without diminishing yield (8), and greater than 95% of the Pd-containing species could be conveniently removed from the sample by HPLC purification (153 ppm). The triflate derived from fluorescein (9) underwent undesired coupling with sodium phenoxide in addition to the desired coupling with the peptide. In accordance with the results in Table 1 , this side reaction could be suppressed by the use of BrettPhos in place of t-BuBrettPhos.
A variety of reactive functional groups were tolerated and demonstrated the robustness of this method. These functional groups include arylamines (10, 11, and 15), alkylamines (11, 12, and 13) an amidine, (12), a ketone (13), a carbamate (14), a carboxylic acid (15) , and a diverse array of heterocycles (10, 11, 12, 14, and 15) . For a number of cases (entries 1, 2, 3 , 5, and 13), we isolated the respective LPd(Ar)X complexes as bench stable reagents for peptide arylation. 3 In other cases, the palladium complexes were generated in situ from the aryl (pseudo)halide and cyclooctadiene-ligated palladium(0) complex A and used without isolation. 23 We anticipate that this in situ protocol would find utility in cases where the isolation of the metal complex is non-trivial or rapid diversification of a peptide target is desired. In all cases, the desired monoarylation product was observed as the major product, although in some cases, diarylation products (1, 2, 3, 6 , and 10) or regioisomeric products (5 and 9) were detected as minor by-products. 24 Notably, Pd triflate complexes had a higher propensity to undergo these undesired pathways, presumably due to the cationic nature of the metal center.
Peptide stapling has proven to be an invaluable tool in increasing the stability, cellpermeability, and enhancing the α-helicity of peptides. 25 While numerous chemical approaches have been reported, only a limited number of strategies can utilize native amino acid residues as a handle for macrocyclization of both synthetic and recombinantly expressed peptides. 26 Furthermore, these approaches often result in the formation of amides or thioethers that can be proteolytically or oxidatively unstable, respectively. Recently, we have reported a lysine stapling strategy with highly electron deficient arenes that proceeds via S N Ar to form chemically and biologically stable constructs that addresses the aforementioned concerns. 27 In the presence of a stapling reagent derived from 1,2-bis(4-bromophenoxy)ethane, p53 peptide with an additional lysine residue underwent facile macrocyclization (Scheme 2). The protocol provided access to both [i, i+4] and [i, i+7] stapled products with comparable efficiencies. In addition to the unreacted starting material, side products derived from arylation with a mono-organometallic species account for the rest of the mass balance. 28 It is expected that the organometallic reagent-based approach will allow for the straightforward modulation of the length and identity of the linkers, a feature that is not feasible with a S N Ar reaction-based strategy.
In conclusion, we have discovered a general lysine arylation method based on the use of preformed or in situ generated LPd(Ar)X complexes. The reaction allows for the formation of N-aryl conjugates, which are more stable than the corresponding S-aryl conjugates. 27 Furthermore, this protocol operates under mild conditions and is selective over most other nucleophilic amino acid residues. The success of this method stems from the use of the biarylphosphine ligands BrettPhos and t-BuBrettPhos in conjunction with the mildly basic sodium phenoxide. We have used this strategy to functionalize complex peptide substrates with a variety of biologically important small molecules and peptide macrocyclization.
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where less than 1% of the C-terminus monoarylation product was detected. Bioconjugation strategy using organometallic reagents and the structure of biarylphosphine ligands.
Scheme 1.
Lysine arylation shows broad substrate scope including introduction of tags, chromophores, and drugs. Table 1 Conditions for efficient arylation of lysine in unprotected peptides. 
